New Journal Website is available at: http://www.journalonweb.com/rcm

Published by: Kowsar

Evaluation of Melissa officinalis (Lemon Balm) Effects on Heart Electrical System

Siyavash Joukar 1 , 2 , * and Haleh Asadipour 2
Authors Information
1 Physiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, IR Iran
2 Department of Physiology and Pharmacology, School of Medicine, Kerman University of Medical Sciences, Kerman, IR Iran
Article information
  • Research in Cardiovascular Medicine: May 2015, 4 (2); e27013
  • Published Online: May 23, 2015
  • Article Type: Research Article
  • Received: January 14, 2015
  • Revised: March 5, 2015
  • Accepted: March 11, 2015
  • DOI: 10.5812/cardiovascmed.4(2)2015.27013

To Cite: Joukar S, Asadipour H. Evaluation of Melissa officinalis (Lemon Balm) Effects on Heart Electrical System, Res Cardiovasc Med. 2015 ;4(2):e27013. doi: 10.5812/cardiovascmed.4(2)2015.27013.

Abstract
Copyright: Copyright © 2015, Research in Cardiovascular Medicine. .
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Moradkhani H, Sargsyan E, Bibak H, Naseri B, Sadat-Hosseini M, Fayazi-Barjin A, et al. Melissa officinalis L., a valuable medicine plant: A review. Med Plant Res J. 2010; 4: 2753-9
  • 2. Basar SN, Zaman R. An Overview of Badranjboya (Melissa officinalis). Int. Res. J Biol Sci. 2013; 2: 107-9
  • 3. Aharizad S, Rahimi MH, Moghadam M, Mohebalipour N. Study of genetic diversity in lemon balm (Melissa officinalis l.) populations based on morphological traits and essential oils content. Annals Biological Res. 2012; 3(12): 5748-53
  • 4. Lemon Balm: An Herb Society of America Guide. 2007;
  • 5. Duke J. Handbook of Medicinal Herbs. 2002; : 896[DOI]
  • 6. Mamedov N, Craker LE. Medicinal Plants Used for the Treatment of Bronchial Asthma in Russia and Central Asia. Journal of Herbs, Spices & Medicinal Plants. 2001; 8(2-3): 91-117
  • 7. Kabeeruddin HM. Maghzanul Mufarradat Almaroof Khawasul Advia. 2000; : 112
  • 8. Lopez V, Martin S, Gomez-Serranillos MP, Carretero ME, Jager AK, Calvo MI. Neuroprotective and neurological properties of Melissa officinalis. Neurochem Res. 2009; 34(11): 1955-61[DOI][PubMed]
  • 9. Kennedy DO, Little W, Scholey AB. Attenuation of laboratory-induced stress in humans after acute administration of Melissa officinalis (Lemon Balm). Psychosom Med. 2004; 66(4): 607-13[PubMed]
  • 10. Cases J, Ibarra A, Feuillere N, Roller M, Sukkar SG. Pilot trial of Melissa officinalis L. leaf extract in the treatment of volunteers suffering from mild-to-moderate anxiety disorders and sleep disturbances. Med J Nutrition Metab. 2011; 4(3): 211-8[DOI][PubMed]
  • 11. Sadraei H, Ghannadi A, Malekshahi K. Relaxant effect of essential oil of Melissa officinalis and citral on rat ileum contractions. Fitoterapia. 2003; 74(5): 445-52[PubMed]
  • 12. Bolkent S, Yanardag R, Karabulut-Bulan O, Yesilyaprak B. Protective role of Melissa officinalis L. extract on liver of hyperlipidemic rats: a morphological and biochemical study. J Ethnopharmacol. 2005; 99(3): 391-8[DOI][PubMed]
  • 13. Akhondzadeh S, Noroozian M, Mohammadi M, Ohadinia S, Jamshidi AH, Khani M. Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomised, placebo controlled trial. J Neurol Neurosurg Psychiatry. 2003; 74(7): 863-6[PubMed]
  • 14. Gazola R, Machado D, Ruggiero C, Singi G, Macedo Alexandre M. Lippia alba, Melissa officinalis and Cymbopogon citratus: effects of the aqueous extracts on the isolated hearts of rats. Pharmacol Res. 2004; 50(5): 477-80[DOI][PubMed]
  • 15. Joukar S, Zarisfi Z, Sepehri G, Bashiri A. Efficacy of Melissa officinalis in suppressing ventricular arrhythmias following ischemia-reperfusion of the heart: a comparison with amiodarone. Med Princ Pract. 2014; 23(4): 340-5[DOI][PubMed]
  • 16. Lionte C, Bologa C, Sorodoc L. Advances in Electrocardiograms - Clinical Applications. Intech. 2014; : 271-97
  • 17. Joukar S, Najafipour H, Dabiri S, Sheibani V, Esmaeili-Mahani S, Ghotbi P, et al. The effect of chronic co-administration of morphine and verapamil on isoproterenol-induced heart injury. Cardiovasc Hematol Agents Med Chem. 2011; 9(4): 218-24[PubMed]
  • 18. Joukar S. Electrocardiogram alterations following one-week consumption of Crocus sativus L.(saffron). EXCLI J. 2012; 11: 480-6
  • 19. Nada A, Gintant GA, Kleiman R, Gutstein DE, Gottfridsson C, Michelson EL, et al. The evaluation and management of drug effects on cardiac conduction (PR and QRS intervals) in clinical development. Am Heart J. 2013; 165(4): 489-500[DOI][PubMed]
  • 20. Kmecova J, Klimas J. Heart rate correction of the QT duration in rats. Eur J Pharmacol. 2010; 641(2-3): 187-92[DOI][PubMed]
  • 21. Epstein AE, Hallstrom AP, Rogers WJ, Liebson PR, Seals AA, Anderson JL, et al. Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction. The original design concept of the Cardiac Arrhythmia Suppression Trial (CAST). JAMA. 1993; 270(20): 2451-5[PubMed]
  • 22. Rodriguez-Menchaca AA, Navarro-Polanco RA, Ferrer-Villada T, Rupp J, Sachse FB, Tristani-Firouzi M, et al. The molecular basis of chloroquine block of the inward rectifier Kir2.1 channel. Proc Natl Acad Sci U S A. 2008; 105(4): 1364-8[DOI][PubMed]
  • 23. Zumbakyte-Sermuksniene R, Kajeniene A, Berskiene K, Daunoraviciene A, Sedereviciute-Kandrataviciene R. Assessment of the effect of anthropometric data on the alterations of cardiovascular parameters in Lithuanian elite male basketball players during physical load. Medicina (Kaunas). 2012; 48(11): 566-71[PubMed]
  • 24. Taggart P, Sutton PM, Opthof T, Coronel R, Trimlett R, Pugsley W, et al. Transmural repolarisation in the left ventricle in humans during normoxia and ischaemia. Cardiovasc Res. 2001; 50(3): 454-62[PubMed]
  • 25. Antzelevitch C, Sicouri S, Litovsky SH, Lukas A, Krishnan SC, Di Diego JM, et al. Heterogeneity within the ventricular wall. Electrophysiology and pharmacology of epicardial, endocardial, and M cells. Circ Res. 1991; 69(6): 1427-49[PubMed]
  • 26. Brunton L, Chabner B, Knollman B. Goodman & Gilmans The pharmacological basis of therapeutics. 2011; : 828-32
  • 27. Gupta A, Lawrence AT, Krishnan K, Kavinsky CJ, Trohman RG. Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes. Am Heart J. 2007; 153(6): 891-9[DOI][PubMed]
  • 28. Antzelevitch C, Shimizu W, Yan G. Electrical heterogeneity and the development of arrhythmias. Dispersion of ventricular repolarization: state of the art. Armonk (NY): Futura Publishing Company, Inc. 2000; : 3-21
  • 29. Sicouri S, Antzelevitch C. A subpopulation of cells with unique electrophysiological properties in the deep subepicardium of the canine ventricle. The M cell. Circ Res. 1991; 68(6): 1729-41[PubMed]
  • 30. Antzelevitch C. Role of spatial dispersion of repolarization in inherited and acquired sudden cardiac death syndromes. Am J Physiol Heart Circ Physiol. 2007; 293(4)-38[DOI][PubMed]
  • 31. Gupta P, Patel C, Patel H, Narayanaswamy S, Malhotra B, Green JT, et al. T(p-e)/QT ratio as an index of arrhythmogenesis. J Electrocardiol. 2008; 41(6): 567-74[DOI][PubMed]
  • 32. Watanabe N, Kobayashi Y, Tanno K, Miyoshi F, Asano T, Kawamura M, et al. Transmural dispersion of repolarization and ventricular tachyarrhythmias. J Electrocardiol. 2004; 37(3): 191-200[PubMed]
  • 33. Yan GX, Antzelevitch C. Cellular basis for the normal T wave and the electrocardiographic manifestations of the long-QT syndrome. Circulation. 1998; 98(18): 1928-36[PubMed]
  • 34. Antzelevitch C, Shimizu W, Yan G, Sicouri S. Cellular basis for QT dispersion. Journal of Electrocardiology. 1998; 30: 168-75
  • 35. Chugh SS, Reinier K, Singh T, Uy-Evanado A, Socoteanu C, Peters D, et al. Determinants of prolonged QT interval and their contribution to sudden death risk in coronary artery disease: the Oregon Sudden Unexpected Death Study. Circulation. 2009; 119(5): 663-70[PubMed]
  • 36. Straus SM, Kors JA, De Bruin ML, van der Hooft CS, Hofman A, Heeringa J, et al. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol. 2006; 47(2): 362-7[DOI][PubMed]
  • 37. Minoura Y, Panama BK, Nesterenko VV, Betzenhauser M, Barajas-Martinez H, Hu D, et al. Effect of Wenxin Keli and quinidine to suppress arrhythmogenesis in an experimental model of Brugada syndrome. Heart Rhythm. 2013; 10(7): 1054-62[DOI][PubMed]
  • 38. Burashnikov A, Petroski A, Hu D, Barajas-Martinez H, Antzelevitch C. Atrial-selective inhibition of sodium-channel current by Wenxin Keli is effective in suppressing atrial fibrillation. Heart Rhythm. 2012; 9(1): 125-31[DOI][PubMed]
  • 39. Joukar S, Ghasemipour-Afshar E, Sheibani M, Naghsh N, Bashiri A. Protective effects of saffron (Crocus sativus) against lethal ventricular arrhythmias induced by heart reperfusion in rat: a potential anti-arrhythmic agent. Pharm Biol. 2013; 51(7): 836-43[DOI][PubMed]
  • 40. Khori V, Alizadeh AM, Yazdi H, Rakhshan E, Mirabbasi A, Changizi S, et al. Frequency-dependent electrophysiological remodeling of the AV node by hydroalcohol extract of Crocus sativus L. (saffron) during experimental atrial fibrillation: the role of endogenous nitric oxide. Phytother Res. 2012; 26(6): 826-32[DOI][PubMed]
  • 41. Ritter M, Melichar K, Strahler S, Kuchta K, Schulte J, Sartiani L, et al. Cardiac and electrophysiological effects of primary and refined extracts from Leonurus cardiaca L. (Ph.Eur.). Planta Med. 2010; 76(6): 572-82[DOI][PubMed]
  • 42. Tai YT, Lau CP, But PP, Fong PC, Li JP. Bidirectional tachycardia induced by herbal aconite poisoning. Pacing Clin Electrophysiol. 1992; 15(5): 831-9[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .